4.4 Article

Decreased prevalence of Plasmodium falciparum resistance markers to amodiaquine despite its wide scale use as ACT partner drug in Zanzibar

Related references

Note: Only part of the references are listed.
Article Microbiology

In Vitro Sensitivities of Plasmodium falciparum to Different Antimalarial Drugs in Uganda

Samuel L. Nsobya et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)

Article Multidisciplinary Sciences

Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine

Juliana Martha Sa et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Public, Environmental & Occupational Health

The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa

Christin Sisowath et al.

TROPICAL MEDICINE & INTERNATIONAL HEALTH (2007)

Article Biochemical Research Methods

Multiplex PCR-RFLP methods for pfcrt, pfmdr1 and pfdhfr mutations in Plasmodium falciparum

MI Veiga et al.

MOLECULAR AND CELLULAR PROBES (2006)

Article Biochemistry & Molecular Biology

A critical role for PfCRT K76T in Plasmodium falciparum verapamil-reversible chloroquine resistance

V Lakshmanan et al.

EMBO JOURNAL (2005)

Article Medicine, General & Internal

A molecular marker for chloroquine-resistant falciparum malaria

A Djimdé et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)